Table 2.
Efavirenz exposure stratification (< or ≥4000 ng/mL) in deficient, insufficient and sufficient values of vitamin D in the two different cohorts and both together. The p-values are obtained through chi squared test (crosstabs).
| Efavirenz < 4000 ng/mL n (%) |
Efavirenz ≥ 4000 ng/mL n (%) |
Total n (%) |
|||
|---|---|---|---|---|---|
| Turin | Deficiency (≤10) | 16 (69.6) | 7 (30.4) | 23 (100) | p = 0.017 |
| Insufficiency (11–30) | 123 (86.0) | 20 (14.0) | 143 (100) | ||
| Sufficiency (>30) | 57 (93.4) | 4 (6.6) | 61 (100) | ||
| Total | 196 (86.3) | 31 (13.7) | 227 (100) | ||
| Rome | Deficiency (≤10) | 3 (27.3) | 8 (72.7) | 11 (100) | p < 0.001 |
| Insufficiency (11–30) | 56 (91.8) | 5 (8.2) | 61 (100) | ||
| Sufficiency (>30) | 17 (100) | 17 (100) | |||
| Total | 76 (85.4) | 13 (14.6) | 89 (100) | ||
| Total | Deficiency (≤10) | 19 (55.9) | 15 (44.1) | 34 (100) | p < 0.001 |
| Insufficiency (11–30) | 179 (87.7) | 25 (12.3) | 204 (100) | ||
| Sufficiency (>30) | 74 (94.9) | 4 (5.1) | 78 (100) | ||
| Total | 272 (86.1) | 44 (13.9) | 316 (100) |